BIOMAT Database Logo BIOMAT Database Logo

Treatment and timing in invasive mould disease. 2011

Johan Maertens, and Andreas H Groll, and Catherine Cordonnier, and Rafael de la Cámara, and Emmanuel Roilides, and Oscar Marchetti
Department of Hematology, Acute Leukemia and Stem Cell Transplantation Unit, University Hospitals Leuven, Campus Gasthuisberg, Herestraat 49, B-3000 Leuven, Belgium. johan.maertens@uz.kuleuven.ac.be

Invasive mould disease is a growing threat for immunocompromised patients. The optimum time to use mould-active antifungal agents is much debated. Current approaches to antifungal prophylaxis, early treatment (empirical and pre-emptive therapy) and treatment of documented mould infections in onco-haematology patients are discussed.

UI MeSH Term Description Entries
D009181 Mycoses Diseases caused by FUNGI. Fungus Diseases,Fungal Diseases,Fungal Infections,Fungus Infections,Disease, Fungal,Disease, Fungus,Diseases, Fungal,Diseases, Fungus,Fungal Disease,Fungal Infection,Fungus Disease,Fungus Infection,Infection, Fungal,Infection, Fungus,Infections, Fungal,Infections, Fungus
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000935 Antifungal Agents Substances that destroy fungi by suppressing their ability to grow or reproduce. They differ from FUNGICIDES, INDUSTRIAL because they defend against fungi present in human or animal tissues. Anti-Fungal Agents,Antifungal Agent,Fungicides, Therapeutic,Antibiotics, Antifungal,Therapeutic Fungicides,Agent, Antifungal,Anti Fungal Agents,Antifungal Antibiotics
D013997 Time Factors Elements of limited time intervals, contributing to particular results or situations. Time Series,Factor, Time,Time Factor
D016867 Immunocompromised Host A human or animal whose immunologic mechanism is deficient because of an immunodeficiency disorder or other disease or as the result of the administration of immunosuppressive drugs or radiation. Immunosuppressed Host,Immunocompromised Patient,Host, Immunocompromised,Host, Immunosuppressed,Hosts, Immunocompromised,Hosts, Immunosuppressed,Immunocompromised Hosts,Immunocompromised Patients,Immunosuppressed Hosts,Patient, Immunocompromised,Patients, Immunocompromised
D018890 Chemoprevention The use of chemical compounds to prevent the development of a specific disease. Chemoprophylaxis

Related Publications

Johan Maertens, and Andreas H Groll, and Catherine Cordonnier, and Rafael de la Cámara, and Emmanuel Roilides, and Oscar Marchetti
[Invasive mould disease in haematological patients].
January 2014, Revista iberoamericana de micologia,
Johan Maertens, and Andreas H Groll, and Catherine Cordonnier, and Rafael de la Cámara, and Emmanuel Roilides, and Oscar Marchetti
Clinical considerations in the early treatment of invasive mould infections and disease.
March 2017, The Journal of antimicrobial chemotherapy,
Johan Maertens, and Andreas H Groll, and Catherine Cordonnier, and Rafael de la Cámara, and Emmanuel Roilides, and Oscar Marchetti
Detection and investigation of invasive mould disease.
January 2011, The Journal of antimicrobial chemotherapy,
Johan Maertens, and Andreas H Groll, and Catherine Cordonnier, and Rafael de la Cámara, and Emmanuel Roilides, and Oscar Marchetti
Second-line treatment in invasive mould infections.
January 2006, Mycoses,
Johan Maertens, and Andreas H Groll, and Catherine Cordonnier, and Rafael de la Cámara, and Emmanuel Roilides, and Oscar Marchetti
Early diagnosis of invasive mould infections and disease.
March 2017, The Journal of antimicrobial chemotherapy,
Johan Maertens, and Andreas H Groll, and Catherine Cordonnier, and Rafael de la Cámara, and Emmanuel Roilides, and Oscar Marchetti
Invasive mould infections in solid organ transplant patients: modifiers and indicators of disease and treatment response.
December 2019, Infection,
Johan Maertens, and Andreas H Groll, and Catherine Cordonnier, and Rafael de la Cámara, and Emmanuel Roilides, and Oscar Marchetti
Invasive mould disease in haematologic patients: comparison between fusariosis and aspergillosis.
October 2018, Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases,
Johan Maertens, and Andreas H Groll, and Catherine Cordonnier, and Rafael de la Cámara, and Emmanuel Roilides, and Oscar Marchetti
Changes in the epidemiological landscape of invasive mould infections and disease.
March 2017, The Journal of antimicrobial chemotherapy,
Johan Maertens, and Andreas H Groll, and Catherine Cordonnier, and Rafael de la Cámara, and Emmanuel Roilides, and Oscar Marchetti
Treatment outcome of invasive mould disease after sequential exposure to azoles and liposomal amphotericin B.
January 2010, The Journal of antimicrobial chemotherapy,
Johan Maertens, and Andreas H Groll, and Catherine Cordonnier, and Rafael de la Cámara, and Emmanuel Roilides, and Oscar Marchetti
Invasive mould infections in newborns and children.
March 2011, Early human development,
Copied contents to your clipboard!